
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/MDPV: Difference between revisions
Jump to navigation
Jump to search
>White Created page with " {{SubstanceBox <!-- Table Properties --> |MaterialTable_MaxWidth=250px |MaterialTable_Title={{PAGENAME}} <!-- Modules --> |ModuleSource=false |Modul..." |
>Sir Kibs No edit summary |
||
Line 1: | Line 1: | ||
{{SubstanceBox | {{SubstanceBox | ||
Line 33: | Line 32: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=The skeletal formula of MDPV | ||
|SkeletalImageFile=File:MDPV.png | |SkeletalImageFile=File:MDPV.png | ||
|SkeletalImageWidth=250px | |SkeletalImageWidth=250px | ||
Line 40: | Line 39: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=MDPV | |NameCommon=MDPV, bath salts | ||
|NameSubstitution=Methylenedioxypyrovalerone | |NameSubstitution=Methylenedioxypyrovalerone | ||
|NameSystematic=1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | |NameSystematic=1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Stimulant]] | |||
|EffectClass= | |ChemicalClass=[[Cathinone]], [[Pyrovalerone]] | ||
|ChemicalClass= | |||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed= | |OralROA_Collapsed= | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation and | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation.<br>'''This dosage and duration information has been sourced from [https://erowid.org/chemicals/mdpv/ Erowid]''' | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold= | |OralROA_Threshold=[[Oral threshold dose::2]] - 6 [[Oral dose units::mg]] | ||
|OralROA_Light= | |OralROA_Light=[[Oral min light dose::4]] - [[Oral max light dose::10]] mg | ||
|OralROA_Common= | |OralROA_Common=[[Oral min common dose::8]] - [[Oral max common dose::15]] mg | ||
|OralROA_Strong= | |OralROA_Strong=[[Oral min strong dose::12]] - [[Oral max strong dose::25]] mg | ||
|OralROA_Heavy= | |OralROA_Heavy=[[Oral heavy dose::25]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration= | |OralROA_Duration=[[Oral min total time::2]] - [[Oral max total time::7]] [[Oral total time units::hours]] | ||
|OralROA_Onset= | |OralROA_Onset=[[Oral min onset time::15]] - [[Oral max onset time::30]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Peak=[[Oral min peak time::1]] - [[Oral max peak time::4]] [[Oral peak time units::hours]] | ||
|OralROA_Offset= | |OralROA_Offset=[[Oral min offset time::0.5]] - [[Oral max offset time::2]] [[Oral offset time units::hours]] | ||
|OralROA_Aftereffects= | |OralROA_Aftereffects=[[Oral min afterglow time::2]] - [[Oral max afterglow time::48]] [[Oral afterglow time units::hours]] | ||
}} | }} |
Revision as of 18:42, 1 December 2016
SubstanceBox/MDPV | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
|||||||||||||||||||||||||||||||
Chemical Nomenclature | |||||||||||||||||||||||||||||||
Common names | MDPV, bath salts | ||||||||||||||||||||||||||||||
Substitutive name | Methylenedioxypyrovalerone | ||||||||||||||||||||||||||||||
Systematic name | 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | ||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||
Psychoactive class | Stimulant | ||||||||||||||||||||||||||||||
Chemical class | Cathinone, Pyrovalerone | ||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||
|